 | • レポートコード：MRC2-11QY07540 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医療用モルヒネのグローバル市場について調査・分析したレポートです。種類別（経口、注射剤）市場規模、用途別（がん、関節炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医療用モルヒネの競争状況、市場シェア ・世界の医療用モルヒネ市場：種類別市場規模 2015年-2020年（経口、注射剤） ・世界の医療用モルヒネ市場：種類別市場規模予測 2021年-2026年（経口、注射剤） ・世界の医療用モルヒネ市場：用途別市場規模 2015年-2020年（がん、関節炎） ・世界の医療用モルヒネ市場：用途別市場規模予測 2021年-2026年（がん、関節炎） ・北米の医療用モルヒネ市場分析：米国、カナダ ・ヨーロッパの医療用モルヒネ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医療用モルヒネ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医療用モルヒネ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医療用モルヒネ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Mallinckrodt Pharmaceuticals、Alcaliber、Purdue Pharma、Pfizer、Sun Pharmaceutical Industries、Taj Pharmaceuticals Limited ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.
The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the morphine market globally positively. The global medical morphine market is consolidated in nature owing to the dominance of few companies in manufacturing and processing. Morphine production is regulated by stringent regulation policies passed by several countries which would hamper its manufacturing. North America dominated the global medical morphine market and is expected to maintain its position in global market attributed to its increasing consumption in the U.S.
Market Analysis and Insights: Global Medical Morphine Market
The global Medical Morphine market size is projected to reach US$ 11240 million by 2026, from US$ 10970 million in 2020, at a CAGR of 2.3%% during 2021-2026.
Global Medical Morphine Scope and Market Size
Medical Morphine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Morphine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Medical Morphine market is segmented into
Oral
Injectables
Segment by Application, the Medical Morphine market is segmented into
Cancer
Arthritis
Regional and Country-level Analysis
The Medical Morphine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Medical Morphine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Medical Morphine Market Share Analysis
Medical Morphine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Medical Morphine business, the date to enter into the Medical Morphine market, Medical Morphine product introduction, recent developments, etc.
The major vendors covered:
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
…
1 Study Coverage
1.1 Medical Morphine Product Introduction
1.2 Market Segments
1.3 Key Medical Morphine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Medical Morphine Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injectables
1.5 Market by Application
1.5.1 Global Medical Morphine Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Arthritis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Medical Morphine Market Size, Estimates and Forecasts
2.1.1 Global Medical Morphine Revenue 2015-2026
2.1.2 Global Medical Morphine Sales 2015-2026
2.2 Global Medical Morphine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Medical Morphine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Medical Morphine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Medical Morphine Competitor Landscape by Players
3.1 Medical Morphine Sales by Manufacturers
3.1.1 Medical Morphine Sales by Manufacturers (2015-2020)
3.1.2 Medical Morphine Sales Market Share by Manufacturers (2015-2020)
3.2 Medical Morphine Revenue by Manufacturers
3.2.1 Medical Morphine Revenue by Manufacturers (2015-2020)
3.2.2 Medical Morphine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Medical Morphine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Medical Morphine Revenue in 2019
3.2.5 Global Medical Morphine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Medical Morphine Price by Manufacturers
3.4 Medical Morphine Manufacturing Base Distribution, Product Types
3.4.1 Medical Morphine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Medical Morphine Product Type
3.4.3 Date of International Manufacturers Enter into Medical Morphine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Medical Morphine Market Size by Type (2015-2020)
4.1.1 Global Medical Morphine Sales by Type (2015-2020)
4.1.2 Global Medical Morphine Revenue by Type (2015-2020)
4.1.3 Medical Morphine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Medical Morphine Market Size Forecast by Type (2021-2026)
4.2.1 Global Medical Morphine Sales Forecast by Type (2021-2026)
4.2.2 Global Medical Morphine Revenue Forecast by Type (2021-2026)
4.2.3 Medical Morphine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Medical Morphine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Medical Morphine Market Size by Application (2015-2020)
5.1.1 Global Medical Morphine Sales by Application (2015-2020)
5.1.2 Global Medical Morphine Revenue by Application (2015-2020)
5.1.3 Medical Morphine Price by Application (2015-2020)
5.2 Medical Morphine Market Size Forecast by Application (2021-2026)
5.2.1 Global Medical Morphine Sales Forecast by Application (2021-2026)
5.2.2 Global Medical Morphine Revenue Forecast by Application (2021-2026)
5.2.3 Global Medical Morphine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Medical Morphine by Country
6.1.1 North America Medical Morphine Sales by Country
6.1.2 North America Medical Morphine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Medical Morphine Market Facts & Figures by Type
6.3 North America Medical Morphine Market Facts & Figures by Application
7 Europe
7.1 Europe Medical Morphine by Country
7.1.1 Europe Medical Morphine Sales by Country
7.1.2 Europe Medical Morphine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Medical Morphine Market Facts & Figures by Type
7.3 Europe Medical Morphine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Medical Morphine by Region
8.1.1 Asia Pacific Medical Morphine Sales by Region
8.1.2 Asia Pacific Medical Morphine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Medical Morphine Market Facts & Figures by Type
8.3 Asia Pacific Medical Morphine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Medical Morphine by Country
9.1.1 Latin America Medical Morphine Sales by Country
9.1.2 Latin America Medical Morphine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Medical Morphine Market Facts & Figures by Type
9.3 Central & South America Medical Morphine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Medical Morphine by Country
10.1.1 Middle East and Africa Medical Morphine Sales by Country
10.1.2 Middle East and Africa Medical Morphine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Medical Morphine Market Facts & Figures by Type
10.3 Middle East and Africa Medical Morphine Market Facts & Figures by Application
11 Company Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
11.1.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mallinckrodt Pharmaceuticals Medical Morphine Products Offered
11.1.5 Mallinckrodt Pharmaceuticals Related Developments
11.2 Alcaliber
11.2.1 Alcaliber Corporation Information
11.2.2 Alcaliber Description and Business Overview
11.2.3 Alcaliber Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alcaliber Medical Morphine Products Offered
11.2.5 Alcaliber Related Developments
11.3 Purdue Pharma
11.3.1 Purdue Pharma Corporation Information
11.3.2 Purdue Pharma Description and Business Overview
11.3.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Purdue Pharma Medical Morphine Products Offered
11.3.5 Purdue Pharma Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Medical Morphine Products Offered
11.4.5 Pfizer Related Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Corporation Information
11.5.2 Sun Pharmaceutical Industries Description and Business Overview
11.5.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sun Pharmaceutical Industries Medical Morphine Products Offered
11.5.5 Sun Pharmaceutical Industries Related Developments
11.6 Taj Pharmaceuticals Limited
11.6.1 Taj Pharmaceuticals Limited Corporation Information
11.6.2 Taj Pharmaceuticals Limited Description and Business Overview
11.6.3 Taj Pharmaceuticals Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Taj Pharmaceuticals Limited Medical Morphine Products Offered
11.6.5 Taj Pharmaceuticals Limited Related Developments
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Corporation Information
11.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
11.1.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mallinckrodt Pharmaceuticals Medical Morphine Products Offered
11.1.5 Mallinckrodt Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Medical Morphine Market Estimates and Projections by Region
12.1.1 Global Medical Morphine Sales Forecast by Regions 2021-2026
12.1.2 Global Medical Morphine Revenue Forecast by Regions 2021-2026
12.2 North America Medical Morphine Market Size Forecast (2021-2026)
12.2.1 North America: Medical Morphine Sales Forecast (2021-2026)
12.2.2 North America: Medical Morphine Revenue Forecast (2021-2026)
12.2.3 North America: Medical Morphine Market Size Forecast by Country (2021-2026)
12.3 Europe Medical Morphine Market Size Forecast (2021-2026)
12.3.1 Europe: Medical Morphine Sales Forecast (2021-2026)
12.3.2 Europe: Medical Morphine Revenue Forecast (2021-2026)
12.3.3 Europe: Medical Morphine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Medical Morphine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Medical Morphine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Medical Morphine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Medical Morphine Market Size Forecast by Region (2021-2026)
12.5 Latin America Medical Morphine Market Size Forecast (2021-2026)
12.5.1 Latin America: Medical Morphine Sales Forecast (2021-2026)
12.5.2 Latin America: Medical Morphine Revenue Forecast (2021-2026)
12.5.3 Latin America: Medical Morphine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Medical Morphine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Medical Morphine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Medical Morphine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Medical Morphine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Medical Morphine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Medical Morphine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Medical Morphine Market Segments
Table 2. Ranking of Global Top Medical Morphine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Medical Morphine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injectables
Table 6. Global Medical Morphine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Medical Morphine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Medical Morphine Sales by Regions 2015-2020 (K MT)
Table 9. Global Medical Morphine Sales Market Share by Regions (2015-2020)
Table 10. Global Medical Morphine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Medical Morphine Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Medical Morphine Sales Share by Manufacturers (2015-2020)
Table 13. Global Medical Morphine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Medical Morphine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Morphine as of 2019)
Table 15. Medical Morphine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Medical Morphine Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Medical Morphine Price (2015-2020) (USD/MT)
Table 18. Medical Morphine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Medical Morphine Product Type
Table 20. Date of International Manufacturers Enter into Medical Morphine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Medical Morphine Sales by Type (2015-2020) (K MT)
Table 23. Global Medical Morphine Sales Share by Type (2015-2020)
Table 24. Global Medical Morphine Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Medical Morphine Revenue Share by Type (2015-2020)
Table 26. Medical Morphine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Medical Morphine Sales by Application (2015-2020) (K MT)
Table 28. Global Medical Morphine Sales Share by Application (2015-2020)
Table 29. North America Medical Morphine Sales by Country (2015-2020) (K MT)
Table 30. North America Medical Morphine Sales Market Share by Country (2015-2020)
Table 31. North America Medical Morphine Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Medical Morphine Revenue Market Share by Country (2015-2020)
Table 33. North America Medical Morphine Sales by Type (2015-2020) (K MT)
Table 34. North America Medical Morphine Sales Market Share by Type (2015-2020)
Table 35. North America Medical Morphine Sales by Application (2015-2020) (K MT)
Table 36. North America Medical Morphine Sales Market Share by Application (2015-2020)
Table 37. Europe Medical Morphine Sales by Country (2015-2020) (K MT)
Table 38. Europe Medical Morphine Sales Market Share by Country (2015-2020)
Table 39. Europe Medical Morphine Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Medical Morphine Revenue Market Share by Country (2015-2020)
Table 41. Europe Medical Morphine Sales by Type (2015-2020) (K MT)
Table 42. Europe Medical Morphine Sales Market Share by Type (2015-2020)
Table 43. Europe Medical Morphine Sales by Application (2015-2020) (K MT)
Table 44. Europe Medical Morphine Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Medical Morphine Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Medical Morphine Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Medical Morphine Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Medical Morphine Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Medical Morphine Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Medical Morphine Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Medical Morphine Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Medical Morphine Sales Market Share by Application (2015-2020)
Table 53. Latin America Medical Morphine Sales by Country (2015-2020) (K MT)
Table 54. Latin America Medical Morphine Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Medical Morphine Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Medical Morphine Revenue Market Share by Country (2015-2020)
Table 57. Latin America Medical Morphine Sales by Type (2015-2020) (K MT)
Table 58. Latin America Medical Morphine Sales Market Share by Type (2015-2020)
Table 59. Latin America Medical Morphine Sales by Application (2015-2020) (K MT)
Table 60. Latin America Medical Morphine Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Medical Morphine Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Medical Morphine Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Medical Morphine Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Medical Morphine Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Medical Morphine Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Medical Morphine Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Medical Morphine Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Medical Morphine Sales Market Share by Application (2015-2020)
Table 69. Mallinckrodt Pharmaceuticals Corporation Information
Table 70. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 71. Mallinckrodt Pharmaceuticals Medical Morphine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Mallinckrodt Pharmaceuticals Product
Table 73. Mallinckrodt Pharmaceuticals Recent Development
Table 74. Alcaliber Corporation Information
Table 75. Alcaliber Description and Major Businesses
Table 76. Alcaliber Medical Morphine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Alcaliber Product
Table 78. Alcaliber Recent Development
Table 79. Purdue Pharma Corporation Information
Table 80. Purdue Pharma Description and Major Businesses
Table 81. Purdue Pharma Medical Morphine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Purdue Pharma Product
Table 83. Purdue Pharma Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Medical Morphine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Sun Pharmaceutical Industries Corporation Information
Table 90. Sun Pharmaceutical Industries Description and Major Businesses
Table 91. Sun Pharmaceutical Industries Medical Morphine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sun Pharmaceutical Industries Product
Table 93. Sun Pharmaceutical Industries Recent Development
Table 94. Taj Pharmaceuticals Limited Corporation Information
Table 95. Taj Pharmaceuticals Limited Description and Major Businesses
Table 96. Taj Pharmaceuticals Limited Medical Morphine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Taj Pharmaceuticals Limited Product
Table 98. Taj Pharmaceuticals Limited Recent Development
Table 99. Global Medical Morphine Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Medical Morphine Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Medical Morphine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Medical Morphine Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Medical Morphine Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Medical Morphine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Medical Morphine Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Medical Morphine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Medical Morphine Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Medical Morphine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Medical Morphine Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Medical Morphine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Medical Morphine Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Medical Morphine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Medical Morphine Players
Table 117. Medical Morphine Customers List
Table 118. Medical Morphine Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Morphine Product Picture
Figure 2. Global Medical Morphine Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injectables Product Picture
Figure 5. Global Medical Morphine Sales Market Share by Application in 2020 & 2026
Figure 6. Cancer
Figure 7. Arthritis
Figure 8. Medical Morphine Report Years Considered
Figure 9. Global Medical Morphine Market Size 2015-2026 (US$ Million)
Figure 10. Global Medical Morphine Sales 2015-2026 (K MT)
Figure 11. Global Medical Morphine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Medical Morphine Sales Market Share by Region (2015-2020)
Figure 13. Global Medical Morphine Sales Market Share by Region in 2019
Figure 14. Global Medical Morphine Revenue Market Share by Region (2015-2020)
Figure 15. Global Medical Morphine Revenue Market Share by Region in 2019
Figure 16. Global Medical Morphine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Medical Morphine Revenue in 2019
Figure 18. Medical Morphine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Medical Morphine Sales Market Share by Type (2015-2020)
Figure 20. Global Medical Morphine Sales Market Share by Type in 2019
Figure 21. Global Medical Morphine Revenue Market Share by Type (2015-2020)
Figure 22. Global Medical Morphine Revenue Market Share by Type in 2019
Figure 23. Global Medical Morphine Market Share by Price Range (2015-2020)
Figure 24. Global Medical Morphine Sales Market Share by Application (2015-2020)
Figure 25. Global Medical Morphine Sales Market Share by Application in 2019
Figure 26. Global Medical Morphine Revenue Market Share by Application (2015-2020)
Figure 27. Global Medical Morphine Revenue Market Share by Application in 2019
Figure 28. North America Medical Morphine Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Medical Morphine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Medical Morphine Sales Market Share by Country in 2019
Figure 31. North America Medical Morphine Revenue Market Share by Country in 2019
Figure 32. U.S. Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Medical Morphine Market Share by Type in 2019
Figure 37. North America Medical Morphine Market Share by Application in 2019
Figure 38. Europe Medical Morphine Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Medical Morphine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Medical Morphine Sales Market Share by Country in 2019
Figure 41. Europe Medical Morphine Revenue Market Share by Country in 2019
Figure 42. Germany Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Medical Morphine Market Share by Type in 2019
Figure 53. Europe Medical Morphine Market Share by Application in 2019
Figure 54. Asia Pacific Medical Morphine Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Medical Morphine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Medical Morphine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Medical Morphine Revenue Market Share by Region in 2019
Figure 58. China Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Medical Morphine Market Share by Type in 2019
Figure 81. Asia Pacific Medical Morphine Market Share by Application in 2019
Figure 82. Latin America Medical Morphine Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Medical Morphine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Medical Morphine Sales Market Share by Country in 2019
Figure 85. Latin America Medical Morphine Revenue Market Share by Country in 2019
Figure 86. Mexico Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Medical Morphine Market Share by Type in 2019
Figure 93. Latin America Medical Morphine Market Share by Application in 2019
Figure 94. Middle East and Africa Medical Morphine Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Medical Morphine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Medical Morphine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Medical Morphine Revenue Market Share by Country in 2019
Figure 98. Turkey Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Medical Morphine Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Medical Morphine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Medical Morphine Market Share by Type in 2019
Figure 105. Middle East and Africa Medical Morphine Market Share by Application in 2019
Figure 106. North America Medical Morphine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 107. North America Medical Morphine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Medical Morphine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. Europe Medical Morphine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Medical Morphine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Asia Pacific Medical Morphine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Medical Morphine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Latin America Medical Morphine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Medical Morphine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Middle East and Africa Medical Morphine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
エネルギーベース非侵襲的医療美学治療システムの世界市場（～2026年） Energy-based non-invasive medical aesthetic treatment systems use sources of energy such as laser, ultrasound, and radio frequency (RF) to treat physical conditions. One of the major contributors to the growth of this market is growing awareness. Market Analysis and Insights: Global Energy-based Non…- 敗血症性関節炎の世界市場（～2026年） Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout…
- 顔用注射剤の世界市場（～2026年） Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore…
- ロボット医用画像システムの世界市場（～2026年） Medical imaging systems help monitor, diagnose, and treat medical conditions by viewing the human body internally. North America region is the largest and fastest-growing market of Robotic Medical Imaging Systems during the forecast period. Market Analysis and Insights: Global Robotic Medical Imagin…
- Web接続型医療機器の世界市場（～2026年） Weight control supplements especially address obesity reduction and weight management. Obesity has been a major health issues all over the globe, which has in turn created a vast marketplace for weight control supplements. Rising obesity and obesity-induced disease prevalence is the key driver prima…